OR WAIT null SECS
July 17, 2023
Westlake’s third fund of $450 million will be used to grow early stage biotechnology companies.
July 13, 2023
Laboratoire HRA Pharma norgestrel is the first daily tablet for nonprescription use to prevent pregnancy.
Eisai’s lecanemab-irmb was converted from an accelerated approval to a traditional approval.
The agency is reviewing the medicines after receiving reports of self-injury and suicidal thoughts in patients using the type 2 diabetes treatments.
July 11, 2023
FDA's approval of Leqembi paves the way for wider coverage of the drug by Medicare and establishes a process for further clinical testing and evaluation of treatments for this widespread, debilitating condition
July 06, 2023
EMA, the European Commission, and HMAs are phasing out the flexible regulations put into place during the pandemic.
Full Marketing Authorization has been granted for Novavax’s COVID-19 vaccine by the European Commission.
July 05, 2023
FDA has approved Roctavian (valoctocogene roxaparvovec-rvox), a gene therapy from BioMarin Pharmaceutical for treating severe hemophilia A in adults.
June 30, 2023
UCB’s rozanolixizumab-noli is approved for treatment of generalized myasthenia gravis in certain adult patient groups.
June 29, 2023
FDA approved Pfizer’s once-weekly human growth hormone analog for treatment of growth failure in pediatric patients.